Supplementary Information: Middle-Up Characterization of the Monoclonal Antibody Infliximab by Capillary Zone Electrophoresis–Mass Spectrometry

Article

LCGC Europe

LCGC EuropeLCGC Europe-03-01-2019
Volume 32
Issue 3

This information is supplementary to the article “Middle-Up Characterization of the Monoclonal Antibody Infliximab by Capillary Zone Electrophoresis-Mass Spectrometry” that was published in the March 2019 issue of LCGC Europe.

This information is supplementary to the article “Middle-Up Characterization of the Monoclonal Antibody Infliximab by Capillary Zone Electrophoresis–Mass Spectrometry” that was published in the March 2019 issue of LCGC Europe.



 

Related Videos
Toby Astill | Image Credit: © Thermo Fisher Scientific
Related Content